Cargando…
Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?
Autores principales: | Webersinke, G, Kranewitter, W, Deutschbauer, S, Zach, O, Hasenschwandtner, S, Wiesinger, K, Erdel, M, Marschon, R, Böhm, A, Tschurtschenthaler, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080213/ https://www.ncbi.nlm.nih.gov/pubmed/24972150 http://dx.doi.org/10.1038/bcj.2014.42 |
Ejemplares similares
-
Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia
por: Kralik, Johanna M, et al.
Publicado: (2011) -
Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3)
por: Malli, Theodora, et al.
Publicado: (2018) -
Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML
por: Diaz de la Guardia, Rafael, et al.
Publicado: (2020) -
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML
por: Issa, Ghayas C., et al.
Publicado: (2022) -
Significance of NPM1 Gene Mutations in AML
por: Hindley, Andrew, et al.
Publicado: (2021)